Development and validation of a Bayesian survival model for inclusion body myositis

Link to Pubmed [PMID] – 31694651

Theor Biol Med Model 2019 Nov;16(1):17

Associations between disease characteristics and payer-relevant outcomes can be difficult to establish for rare and progressive chronic diseases with sparse available data. We developed an exploratory bridging model to predict premature mortality from disease characteristics, and using inclusion body myositis (IBM) as a representative case study.